allumbra

About

allumbra (formerly illumifyDx) is a liquid biopsy diagnostics company striving to be the leader in optical spectroscopy-based clinical diagnostics by identifying unmet clinical needs and engineering solutions that are rigorous, easy to use, and above all, improve patients’ quality of life. We are currently developing a blood and saliva-based test for the early detection of head and neck cancer.

Product

Value proposition

allumbra combines quantum sensing with AI to extract rich molecular information from blood to create powerful tests that detect cancer sooner

Target customers

healthcare providers, hospitals, clinics, diagnostic laboratories

Founders

• Maria Navas-Moreno, PhD — CEO & CO-FOUNDER
• Randy Carney, PhD — CSO & CO-FOUNDER

Categories

Products

Key features

Technologies

Target conditions

Care settings

News

• Maria Navas-Moreno's Post - LinkedIn · 2026-06-11T00:00:00.000Z
• Startup Storytelling in Healthcare with Techstars AI Health Baltimore · 2026-05-19T00:00:00.000Z
• Meet Allumia Ventures: Healthcare-focused fund backed by Providence eyes new investments – GeekWire · 2025-01-08T02:25:09.000Z
• Providence spins out venture capital arm, invests $150M in 3rd fund | Becker's · 2025-01-07T15:16:07.000Z
• Umbra Health Advocacy needs Gusto Impact Award to help Medicare recipients | Umbra Health Advocacy posted on the topic | LinkedIn · 2025-11-21T20:24:07.000Z
• Affect Therapeutics Raises $26 Million Series B — Allumia Ventures – Healthcare Venture Capital Firm · 2025-09-23T15:36:09.000Z

Browse related software

• Clinic software in CO
• Clinic software in Broomfield
• HealthTech software
• AI/ML in Healthcare software
• Health AI software
• MedTech software
• All clinic software companies A–Z